Deep, qualified future-technology sequencing has discovered that subclonal mutations (i.e., Those people current in only a portion of tumor cells) might be detected for all driver genes and therefore are associated with fast disease development and lousy final result.eleven–13 This is especially pertinent for TP53 See "Qualified therapies in CLL: https://garrye813jhh5.wikirecognition.com/user